- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Bernstein reiterates Outperform rating on Insulet stock with $410 target | ||
| Fr | Moderna stock remains Buy at UBS as analyst sees strong pipeline progress | ||
| Fr | Insulet stock holds Buy rating at UBS on strong growth outlook | ||
| Fr | Molina Healthcare stock price target lowered to $182 by Bernstein SocGen | ||
| Fr | Abbott Labs stock gains as UBS reiterates Buy rating on Exact Sciences deal | ||
| Fr | Bernstein raises Centene stock price target to $45 on Marketplace margin recovery | ||
| Fr | Jacobs Engineering stock plunges despite Bernstein reiterating Outperform rating | ||
| Fr | Bernstein reiterates Outperform rating on Chipotle stock amid growth concerns | ||
| Fr | UBS reiterates Buy rating on NextEra Energy stock with $96 price target | ||
| Fr | Enterprise Products Partners stock maintains Buy rating at UBS | ||
| Fr | Iveda expands in Egypt with new manufacturing partnership | ||
| Fr | FDA accepts Sangamo's rolling BLA submission for Fabry disease gene therapy | ||
| Fr | Bridger Aerospace announces CFO retirement and succession plan | ||
| Fr | Horizon Aircraft developing X7 to fly in clouds and icing conditions | ||
| Fr | Asian patients show comparable results with Zio heart monitoring | ||
| Fr | GameSquare launches FaZe Esports Pass on Clout platform | ||
| Fr | Clear Channel wins 10-year contract extension at DC airports | ||
| Fr | Vera Bradley appoints Ivan Brockman to board of directors | ||
| Fr | VCI Global CEO expands ownership stake through open-market purchases | ||
| Fr | Solstice Gold completes $1.12M private placement financing | ||
| Fr | Jack in the Box stock rebuilds in 2026 as UBS maintains Neutral rating | ||
| Fr | UBS raises Ross Stores stock price target to $169 on department store outgrowth | ||
| Fr | Six Flags stock price target lowered to $27 by UBS on park underperformance | ||
| Fr | Valero Energy stock rating reiterated at Buy by UBS on strong margins | ||
| Fr | Ultragenyx Pharma stock rating reiterated at Overweight by Cantor Fitzgerald |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .